Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $3.23 Million - $3.46 Million
-103,682 Reduced 23.95%
329,146 $10.9 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $117,049 - $127,087
3,788 Added 0.88%
432,828 $13.6 Million
Q2 2022

Aug 15, 2022

BUY
$23.75 - $31.69 $4.3 Million - $5.73 Million
180,951 Added 72.94%
429,040 $13.1 Million
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $2.71 Million - $3.65 Million
-135,569 Reduced 35.34%
248,089 $6.24 Million
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $3.22 Million - $3.98 Million
-184,311 Reduced 32.45%
383,658 $7.83 Million
Q3 2021

Nov 12, 2021

SELL
$17.35 - $22.5 $1.94 Million - $2.52 Million
-112,002 Reduced 16.47%
567,969 $10.9 Million
Q2 2021

Aug 16, 2021

BUY
$18.01 - $28.32 $878,491 - $1.38 Million
48,778 Added 7.73%
679,971 $15.1 Million
Q1 2021

May 17, 2021

SELL
$19.76 - $29.89 $180,487 - $273,015
-9,134 Reduced 1.43%
631,193 $16.6 Million
Q4 2020

May 17, 2021

SELL
$15.73 - $21.66 $297,941 - $410,262
-18,941 Reduced 2.87%
640,327 $12 Million
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $2.8 Million - $3.86 Million
-178,013 Reduced 21.26%
659,268 $12.3 Million
Q3 2020

Nov 16, 2020

SELL
$13.54 - $26.41 $1.75 Million - $3.42 Million
-129,507 Reduced 13.4%
837,281 $14.2 Million
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $1.58 Million - $4.7 Million
201,885 Added 26.39%
966,788 $22.5 Million
Q1 2020

May 14, 2020

BUY
$5.57 - $11.5 $1.36 Million - $2.81 Million
244,478 Added 46.98%
764,903 $6.43 Million
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $647,136 - $830,628
81,916 Added 18.68%
520,425 $5.08 Million
Q3 2019

Nov 14, 2019

BUY
$9.17 - $12.01 $1.51 Million - $1.98 Million
164,828 Added 60.23%
438,509 $4.16 Million
Q2 2019

Aug 15, 2019

BUY
$10.88 - $17.6 $2.98 Million - $4.82 Million
273,681 New
273,681 $3.25 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.